The Bermuda Triangle: The Pragmatics, Policies, and Principles for Data Sharing in the History of the Human Genome Project

Abstract

The Bermuda Principles for DNA sequence data sharing are an enduring legacy of the Human Genome Project (HGP). They were adopted by the HGP at a strategy meeting in Bermuda in February of 1996 and implemented in formal policies by early 1998, mandating daily release of HGP-funded DNA sequences into the public domain. The idea of daily sharing, we argue, emanated directly from strategies for large, goal-directed molecular biology projects first tested within the ''community'' of C. elegans researchers, and were introduced and defended for the HGP by the nematode biologists John Sulston and Robert Waterston. In the C. elegans community, and subsequently in the HGP, daily sharing served the pragmatic goals of quality control and project coordination. Yet in the HGP human genome, we also argue, the Bermuda Principles addressed concerns about gene patents impeding scientific advancement, and were aspirational and flexible in implementation and justification. They endured as an archetype for how rapid data sharing could be realized and rationalized, and permitted adaptation to the needs of various scientific communities. Yet in addition to the support of Sulston and Waterston, their adoption also depended on the clout of administrators at the US National Institutes of Health (NIH) and the UK nonprofit charity the Wellcome Trust, which together funded 90% of the HGP human sequencing effort. The other nations wishing to remain in the HGP consortium had to accommodate to the Bermuda Principles, requiring exceptions from incompatible existing or pending data access policies for publicly funded research in Germany, Japan, and France. We begin this story in 1963, with the biologist Sydney Brenner's proposal for a nematode research program at the Laboratory of Molecular Biology (LMB) at the University of Cambridge. We continue through 2003, with the completion of the HGP human reference genome, The authors gratefully dedicate this article to Sir John Sulston (27 March 1942-6 March 2018), who sadly did not live to see this paper in print, but who reviewed it and contributed greatly to it. His vision for open science guided the public Human Genome Project, based on science to benefit society. He is missed.

Researcher Perspectives on Data Sharing in Deep Brain Stimulation

“…These concerns were met with solutions similar to what our researcher-participants proposed, notably with the implementation of the Fort Lauderdale Agreement and acceptance of the Bermuda Principles, which provided both rapid access to data and publication priority for researchers who generated a given dataset (Kaye et al, 2009;Contreras, 2011). The Bermuda Principles allowed for the achievement of rapid sharing in the spirit of open science while remaining flexible and responsive to the needs of the scientific community (Jones et al, 2018).…”

Building and sustaining collaborative platforms in genomics and biobanks for health innovation

“…However, the goals of generating private investment and promoting public value and social innovation are not always aligned, with implications for public trust (Livesey, 2019[29]; Stark et al, 2019 [5]). Transparent and inclusive governance frameworks and business plans can help define the terms of the social contract, to strengthen social innovation, and to promote the value of genomic and biobank collaborative platforms (Hofman et al, 2014[33]; Matzke et al, 2016 [35]).…”

Investigación en México sobre medicamentos biotecnológicos, ingeniería de tejidos y biosensores para diagnóstico

“…In the 60's and 70's, significant studies started to bloom and sparked new research areas that have now revolutionized the biomedical field, such as, genome sequencing studies which led to the development of biotechnological drugs (Maxson Jones, Ankeny, & Cook-Deegan, 2018); the study of stem cells for regenerative medicine (Anzaldúa Arce et al, 2007); and the research in nanotechnology which gave to biosensors (Qing et al, 2019).…”

“…The genome sequence of C. elegans, proposed in 1963 by the biologist Sydney Brenner from Cambridge University, began a new biotechnological era, which had another important inflexion point between 1990 and 2003 when the human genome was fully sequenced (Maxson Jones et al, 2018). The Human Genome Project began as a consortium, until 2000 when the Celera Genomics led by Dr. Craig Venter joined the cause (Martínez, 2010).…”

“…The Human Genome Project began as a consortium, until 2000 when the Celera Genomics led by Dr. Craig Venter joined the cause (Martínez, 2010). Nevertheless, thanks to the "Bermuda Principles" from 1996 all this information is of public domain (Maxson Jones et al, 2018). Therefore even though Mexico did not participate in the project, important studies have been done in genomic medicine with the information provided by it (Martínez, 2010), for instance, the search for biomarkers for the diagnostic and treatment of multiple diseases (Manzanarez-Ozuna, Flores, Gutiérrez-López, Cervantes, & Juárez, 2018;Weissglas-Volkov et al, 2010).…”